Literature DB >> 10896508

Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus.

H Komatsuzawa1, K Ohta, M Sugai, T Fujiwara, P Glanzmann, H Suginaka.   

Abstract

A Tn551 insert in a gene termed fmtB was shown to reduce oxacillin as well as Triton X-100 resistance in highly methicillin-resistant Staphylococcus aureus (MRSA) COL. Backcrosses of fmtB::Tn551 into S. aureus COL and into two genetically distinct MRSA strains, KSA8 and NCTC10443, confirmed the linkage of fmtB::Tn551 with loss of oxacillin resistance. The fmtB gene codes for a protein of a deduced molecular mass of 263 kDa that contains 17 tandem repeats of 75 amino acids and a C-terminal LPXTG cell wall-sorting motif. Immunoblots with anti-FmtB antibodies confirmed its localization in the cell wall fraction. The fmtB gene was mapped downstream of the phosphoglucosamine mutase operon glmM which catalyses formation of glucosamine-1-phosphate. Oxacillin resistance was not restored in fmtB mutants by trans-complementation with fmtB. However, although GlmM production was not affected by fmtB inactivation, oxacillin resistance was increased in fmtB mutants by introducing a plasmid-borne glmM gene, presumably by GlmM overexpression. Interestingly, a similar phenotypic complementation was obtained in fmtB mutants by including substrate level concentrations of N-acetylglucosamine or glucosamine in the growth medium. Inactivation of the fmtB gene seems therefore to have an indirect effect on methicillin resistance which can be relieved by increasing the production of the cell wall precursor glucosamine-1-phosphate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896508     DOI: 10.1093/jac/45.4.421

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Christine Barras; Patrice François; Yvan Charbonnier; Elzbieta Huggler; Christian Garzoni; William L Kelley; Paul Majcherczyk; Jacques Schrenzel; Daniel P Lew; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 2.  Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

Authors:  Leticia I Llarrull; Jed F Fisher; Shahriar Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

3.  Antibacterial activity of oxyresveratrol against methicillin-resistant Staphylococcus aureus and its mechanism.

Authors:  Dae-Ki Joung; Su-Hyun Mun; Sung-Hoon Choi; Ok-Hwa Kang; Sung-Bae Kim; Young-Seob Lee; Tian Zhou; Ryong Kong; Jang-Gi Choi; Dong-Won Shin; Youn-Chul Kim; Dong-Sung Lee; Dong-Yeul Kwon
Journal:  Exp Ther Med       Date:  2016-06-27       Impact factor: 2.447

4.  The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response.

Authors:  Aurélia Delauné; Sarah Dubrac; Charlène Blanchet; Olivier Poupel; Ulrike Mäder; Aurélia Hiron; Aurélie Leduc; Catherine Fitting; Pierre Nicolas; Jean-Marc Cavaillon; Minou Adib-Conquy; Tarek Msadek
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

5.  Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus.

Authors:  Simon R Clarke; Llinos G Harris; R Geoff Richards; Simon J Foster
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

Authors:  Agnieszka Dryla; Sonja Prustomersky; Dieter Gelbmann; Markus Hanner; Edith Bettinger; Béla Kocsis; Tamás Kustos; Tamás Henics; Andreas Meinke; Eszter Nagy
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

7.  The giant protein Ebh is a determinant of Staphylococcus aureus cell size and complement resistance.

Authors:  Alice G Cheng; Dominique Missiakas; Olaf Schneewind
Journal:  J Bacteriol       Date:  2013-12-20       Impact factor: 3.490

8.  Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus.

Authors:  D Ashley Robinson; Mark C Enright
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus.

Authors:  Kazuhisa Ouhara; Hitoshi Komatsuzawa; Toshihisa Kawai; Hiromi Nishi; Tamaki Fujiwara; Yoshihiro Fujiue; Masao Kuwabara; Koji Sayama; Koji Hashimoto; Motoyuki Sugai
Journal:  J Antimicrob Chemother       Date:  2008-03-26       Impact factor: 5.790

10.  Molecular characterization of a novel Staphylococcus aureus surface protein (SasC) involved in cell aggregation and biofilm accumulation.

Authors:  Katrin Schroeder; Mario Jularic; Samantha M Horsburgh; Nina Hirschhausen; Claudia Neumann; Anne Bertling; Anja Schulte; Simon Foster; Beate E Kehrel; Georg Peters; Christine Heilmann
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.